| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/16/2006 | EP1689741A1 Benzoyl amino pyridyl carboxylic acid derivatives as glucokinase activators |
| 08/16/2006 | EP1689714A2 Therapeutic use of pyridinium compounds to modulate naadp activity |
| 08/16/2006 | EP1689710A1 Indole derivatives for use as chemical uncoupler |
| 08/16/2006 | EP1689707A1 Novel compounds for the treatment of obesity |
| 08/16/2006 | EP1689700A1 Novel salicylic anilides |
| 08/16/2006 | EP1689415A1 Agents for improving iron uptake |
| 08/16/2006 | EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 08/16/2006 | EP1689412A2 Vitamin d analogs for obesity prevention and treatment |
| 08/16/2006 | EP1689392A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 08/16/2006 | EP1689249A1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1469827A4 Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1191019B1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1181020B1 Vitamin d derivatives for the teatment of systemic lupus erythematosus |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/16/2006 | CN1817907A Recombinant solvent protein, its production and use |
| 08/16/2006 | CN1817904A Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use |
| 08/16/2006 | CN1817903A Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/16/2006 | CN1817861A Benzyloxy-substituted tryptophan derivative, its analogs, production and use thereof |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817363A Medicine for treating various diseases |
| 08/16/2006 | CN1817350A Silkworm sand total alkaloid and preparation thereof |
| 08/16/2006 | CN1817347A Medicinal composition with miglinon and proactidil as active components, and preparing method and use thereof |
| 08/16/2006 | CN1817345A Miglinon drops and preparing method thereof |
| 08/16/2006 | CN1817341A Solid sustained preparation of miglinon and its preparing method |
| 08/16/2006 | CN1817252A Cigarette made from mulberry leaf |
| 08/16/2006 | CN1817163A Formulation of Pueraria Mulberry |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269835C Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269528C Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 08/16/2006 | CN1269516C Medicine for defatting and face nourishing |
| 08/16/2006 | CN1269485C Compound comprised royal jelly and lecithin and nutrient composition comprising said compound |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091245 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091212 Chiral dinapsoline |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091010 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7090887 Oilseed processing |
| 08/15/2006 | US7090874 comprises curcumin for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity, hypertension or arterosclerotic cardiovascular disorders |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2395231C Hydrogel-driven layered drug dosage form |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083781A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083645A2 Formulations and dosing regimen for ppar-alpha modulators |
| 08/10/2006 | WO2006083051A1 G6pd enzyme inhibitor and method for treating obesity using the same |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082771A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component 1-aminocyclopropanecarboxylic acid or the like |
| 08/10/2006 | WO2006082743A1 Therapeutic agent |
| 08/10/2006 | WO2006082643A1 Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy |
| 08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
| 08/10/2006 | WO2006082401A1 Chemical compounds |
| 08/10/2006 | WO2006082400A1 Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| 08/10/2006 | WO2006082089A1 Oral dosage form comprising rosiglitazone |
| 08/10/2006 | WO2006082002A1 Imidazole derivatives |
| 08/10/2006 | WO2006081739A1 A composition for treating or preventing hyperlipemia, hypertension and hepatic adipose infiltration |
| 08/10/2006 | WO2006081669A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | WO2006081616A1 Classes of compounds that interact with integrins |
| 08/10/2006 | WO2006070208A8 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists |
| 08/10/2006 | WO2006060920A8 Novel uses of egf |
| 08/10/2006 | WO2006058628A3 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 08/10/2006 | WO2006034440A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 08/10/2006 | WO2005097103A3 Diabetes and metabolic syndrome therapy utilizing cathepsin b inhibitors |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |